Alopecia Areata in Children and Adolescents: More Than Just Skin Deep

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Pfizer Inc.

Activity Description

Alopecia Areata (AA) is a systemic autoimmune condition that usually starts in childhood, affects all age groups, and imparts a severe impact and burden, especially in children and adolescents. The therapeutic landscape for severe AA has expanded with the recent approval of Janus kinase inhibitor therapy, providing an important new treatment option that may improve outcomes for those with this condition. Education on evidence-based approaches to diagnosis, assessment, management of pediatric AA is required to stay up to date with the latest developments in the field. This interactive infographic activity addresses the pathophysiology and burden of AA and reviews best practices for diagnosis and management of pediatric and adolescent patients. Modules will also highlight the current clinical evidence and describe strategies for incorporating patient-focused care to lessen the negative impacts of AA on patient quality of life.

Target Audience

The intended audience for this activity is dermatologists, pediatric dermatologists, pediatricians, nurse practitioners, and physician associates involved in the management of children and adolescent patients with alopecia areata (AA).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Detail the prevalence, burden, and pathophysiology of AA in children and adolescents
• Utilize diagnostic and assessment tools that effectively distinguish as well as measure the severity of AA in children and adolescents
• Select treatments for AA that are efficacious, safe, and improve quality of life in children and adolescents
• Incorporate patient-focused, interprofessional care that improves the well-being and quality of life in children and adolescents with AA

Activity Chair

Brett King, MD, PhD
Associate Professor of Dermatology
Yale School of Medicine
New Haven, CT

Faculty

Brittany Craiglow, MD
Associate Adjunct Professor
Yale School of Medicine
New Haven, CT

Maryanne Makredes Senna, MD
Director
Lahey Hair Loss Center of Excellence
Burlington, MA
Associate Professor of Dermatology
Harvard Medical School
Boston, MA

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Upon successful completion, learners who opt in by providing their ABP ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.

This enduring material is approved for 1 year from the date of original release, April 24, 2024, to April 23, 2025

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or AAPA Category 1 CME Certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Brittany Craiglow, MD
Consultant: Incyte, Lilly, Pfizer
Speaker Contracted by Ineligible Company: AbbVie, Incyte, Lilly, Pfizer

Brett King, MD, PhD
Advisor: AbbVie, Arena, Aslan, Bioniz, BMS, Concert Pharmaceuticals, Equillium, Horizon, Incyte, Janssen, LEO Pharma, Lilly, Pfizer, Q32 Bio, Sun, Viela Bio
Consultant: AbbVie, Arena, Aslan, Bioniz, BMS, Concert Pharmaceuticals, Equillium, Horizon, Incyte, Janssen, LEO Pharma, Lilly, Pfizer, Q32 Bio, Sun, Viela Bio
Speaker Contracted by Ineligible Company: AbbVie, Incyte, Lilly, Pfizer
Clinical Trial Investigator: Aslan, BMS, Concert Pharmaceuticals, Lilly, Pfizer, Q32 Bio

Maryanne Makredes Senna, MD
Consultant: AbbVie, Inmagene, Lilly, Pfizer
Speaker Contracted by Ineligible Company: Lilly, Pfizer
Independent Research Contractor: Concert, Leo, Lilly

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:

• Specify the copyrighted work you believe has been infringed upon.
• Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
• Share your name, address, telephone number, and, if available, your email address.
• Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
• Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
• Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614

CE Questions?

Contact us at cme@vindicoCME.com